Adalimumab: a new modality for Behçet's disease?

This publication has 9 references indexed in Scilit:

• [Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].
  2006
• Current Concepts in the Etiology and Treatment of Behçet Disease
  Survey of Ophthalmology, 2005
• The Benefit/Risk Profile of TNF-Blocking Agents: Findings of a Consensus Panel
  Seminars in Arthritis and Rheumatism, 2005
• Anti-TNF- therapy for sight threatening uveitis
  British Journal of Ophthalmology, 2005
• Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review
  Autoimmunity Reviews, 2005
• Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
  2005
• Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis
  Seminars in Arthritis and Rheumatism, 2003
• Vγ9Vδ2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens
  Journal of Neuroimmunology, 2002
• Behçet's Disease
  New England Journal of Medicine, 1999